DUBLIN, March 30, 2021 /PRNewswire/ -- The "Global Cell and Gene Therapy Drug Delivery Devices Market: Focus on Product Type, Commercialized Drug Delivery Devices, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
The global cell and gene therapy drug delivery devices market was valued at $55.75 thousand in 2019, and is expected to reach $375.13 thousand by 2030, registering a CAGR of 16.61% during the forecast.
Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge. Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy. Cell and gene therapies may offer longer-lasting effects than traditional medicines.
One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy. Various market players are actively investing in the research and development of the cell and gene therapy industry. The players are offering improved and new products, which meet the critical needs of patients.
The growth is attributed to major drivers in this market such as the increasing prevalence of cancer and chronic diseases, increased funding in the cell and gene therapy market, rising need to develop novel treatment options for rare diseases, and rising biopharmaceutical R&D expenditure, and rising number of the FDA approvals of cell and gene therapies & clinical trials. The market is expected to grow at a significant growth rate due to various potential opportunities of growth that lie within its domain, which include drug approvals and strong pipeline of cell and gene therapies.
Various new cell and gene-based therapy approaches use biological engineering to improve the immune system's capacity to fight disease while sparing healthy tissues in the body. For instance, there are antibody-based therapies that can make T-cells more effective by increasing their interactions with cancer cells. Other modifications, such as adding complexity to the CAR-T and cancer cell interaction, which can further sharpen T-cells' cancer-targeting ability by reducing damage to normal cells.
The increase in the geriatric population and an increasing number of cancer cases, and genetic disorders across the globe are expected to translate into significantly higher demand for cell and gene therapy drug delivery devices market.
Furthermore, the companies are investing huge amount in research and development of cell and gene therapies and associated drug delivery devices products. The clinical trial landscape of various genetic and chronic diseases has been on the rise in the recent years, this will fuel the cell and gene therapy drug delivery devices market in future.
Within the research report, the market is segmented based on product type, commercialized drugs, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The exponential rise in the application of precision medicine on a global level has created a buzz among companies to invest in the development of novel cell and gene therapy drug delivery devices.
Due to the diverse product portfolio and intense market penetration, Novartis AG, Kite Pharma Inc., and Dendreon Pharmaceuticals LLC. have been the pioneers in this field and been the major competitors in this market.
The other major contributors of the market include companies such as Vericel Corporation, Amgen Inc., Bausch & Lomb Incorporated, Spark Therapeutics, Inc., and Becton, Dickinson and Company.
Based on region, North America holds the largest share of cell and gene therapy drug delivery devices market due to substantial investments made by biotechnology and pharmaceutical companies, improved healthcare infrastructure, rise in per capita income, early availability of approved therapies, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.
Key Topics Covered:
1 Technology Definition
2 Research Scope
3 Key Questions Answered in the Report
4 Research Methodology
5 Market Overview5.1 Introduction5.2 Cell and Gene Therapies and Drug Delivery Devices Industry5.3 Cell and Gene Therapy Drugs and Their Clinical Importance5.4 Cell and Gene Therapy Drug Delivery Devices Market: Current Scenario5.5 Cell and Gene Therapy Drug Delivery Devices Market: Future Perspective
6 Global Cell and Gene Therapy Drug Delivery Devices Market and Growth Potential, 2020-20306.1 Overview6.2 Pipeline Analysis6.2.1 Drug Delivery Systems in Development: Current Scenario6.2.1.1 Ongoing Clinical Trials of Drug Delivery Systems6.2.1.2 Limitations of Cell and Gene Therapy Drug Delivery Devices6.2.1.3 Recent Advancements in Gene Therapy Drug Delivery6.3 Cell and Gene Therapy Drug Delivery Devices Market and Growth Potential6.4 Cell and Gene Therapy Drug Development and Commercialization Landscape6.5 Impact of COVID-19 on Cell and Gene Therapy Drug Delivery Devices Market6.5.1 Impact of COVID-19 on Global Cell and Gene Therapy Drug Delivery Devices Market Growth Rate6.5.2 Impact of COVID-19 on Supply Chain of Cell and Gene Therapy Drug Delivery Devices Market6.5.3 Clinical Trial Disruptions and Resumptions
7 Emerging Technology Landscape7.1 Potential Technologies in Cell and Gene Therapy Drug Delivery Devices Market7.2 Microchip Technology7.3 Nanotechnology-Based Drug Delivery Devices7.4 Lipid Nanoparticles in Gene Therapy
8 Market Dynamics8.1 Impact Analysis8.2 Market Drivers8.2.1 Increasing Prevalence of Cancer and Chronic Diseases8.2.2 Increased Funding of Cell and Gene Therapies8.2.3 Rising Number of FDA Approvals of Cell and Gene Therapies, and Clinical Trials8.3 Market Restraints8.3.1 Stringent Legal Requirements and Regulations8.3.2 Injuries and Infections Caused by Needles8.4 Market Opportunities8.4.1 Strong Pipeline of Cell and Gene Therapies
9 Industry Insights9.1 Regulatory Scenario of Cell and Gene Therapy Drug Delivery Devices Market9.1.1 Overview9.1.2 Risk Assessment of Medical Devices9.1.3 Regulation of Medical Devices in the U.S.9.1.4 Regulation of Medical Devices in Europe9.1.5 Regulation of Medical Devices in Asia-Pacific9.2 Pricing and Reimbursement of Cell and Gene Therapy Drug Delivery Devices
10 Patent Landscape
11 Global Cell and Gene Therapy Drug Delivery Devices Market (by Product Type)11.1 Overview11.2 Subretinal Injection Cannula11.3 Extension Tube11.4 Intravenous Catheter11.5 Sterile Insulin Syringe11.5.1 Sterile Insulin Syringe (Size 1.0 ML, 31-Gauge Needle)11.5.2 Sterile Insulin Syringe (Size 0.5 ML, 22 Gauge Needle)11.6 Pre-Filled Syringe11.6.1 Pre-Filled Syringe (Size 1.0 ML, 22-26 Gauge Needle)11.6.2 Pre-Filled Syringe (Size 4.0 ML, 22-26 Gauge Needle)11.7 Infusion Bags11.7.1 Infusion Bags (Size 10 ML to 50 ML)11.7.2 Infusion Bags (Size 68 ML)11.7.3 Infusion Bags (Size 60 ML)11.7.4 Infusion Bags (Size Up to 65 ML)
12 Global Cell and Gene Therapy Drug Delivery Devices Market (by Commercialized Drugs)12.1 Commercialized Drugs12.1.1 Luxturna12.1.2 Kymriah12.1.3 Provenge12.1.4 Zolgensma12.1.5 Yescarta12.1.6 Strimvelis
13 Global Cell and Gene Therapy Drug Delivery Devices Market (by Region)13.1 Overview
14 Competitive Landscape14.1 Key Developments and Strategies14.1.1 Overview14.1.2 Regulatory and Legal Developments14.1.3 Synergistic Activities14.1.4 M&A Activities14.1.5 Funding Activities14.2 Market Share Analysis
15 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/2mcxqt
Media Contact:
Research and Markets Laura Wood, Senior Manager [emailprotected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
http://www.researchandmarkets.com
- The Ethical, Legal, and Social Issues Impacted by Modern ... - Hindawi - November 25th, 2022
- BSGM - The British Society for Genetic Medicine - November 25th, 2022
- Feasibility and ethics of using data from the Scottish newborn blood spot archive for research | Communications Medicine - Nature.com - October 7th, 2022
- Closing your health care practice: What you need to know - Medical Economics - October 7th, 2022
- Is the doctor's office heading for extinction? - Medical Economics - October 7th, 2022
- Abortion Access in the U.S.: What to Know on a State-By-State Level - Healthline - October 7th, 2022
- Students can create their own path with new ASU Online biology degree - ASU News Now - October 7th, 2022
- U.S. Releases an AI Bill Of Rights That Though Encouraging Won't Yet Move the Needle - JURIST - October 7th, 2022
- California Funds Research On Blocking Marijuana Monopolies And Protecting 'Legacy' Cannabis Strains - Marijuana Moment - October 7th, 2022
- Tips For Your Virtual Meetings With The FDA - Med Device Online - October 7th, 2022
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed ... - The Bakersfield Californian - October 7th, 2022
- MeiraGTx Announces the Upcoming Presentation of 15 Abstracts at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress -... - October 7th, 2022
- Neighborhood deprivation and coronary heart disease in patients with bipolar disorder | Scientific Reports - Nature.com - October 7th, 2022
- Have Insurers Paid Too Much for Asbestos and Other Toxic Torts? - Claims Journal - August 19th, 2022
- Restrictive abortion laws are limiting the options parents have after receiving genetic test results, experts say - Yahoo Singapore News - August 19th, 2022
- Neurologists Discuss the Impact of Roe v. Wade Reversal on... : Neurology Today - LWW Journals - August 19th, 2022
- Abortion ruling prompts variety of reactions from states - ABC News - August 19th, 2022
- Is pregnancy possible after multiple failed IVF attempts? Can your frozen eggs and sperm be as healthy later? - The Indian Express - August 19th, 2022
- Meet the Expert: Focus on orthopaedics and VTE - Hospital Healthcare Europe - August 19th, 2022
- Egg Donation Process: From Application to Recovery - Healthline - July 6th, 2021
- Patent protection of mRNA vaccines and regulatory authorization - Lexology - July 6th, 2021
- EAPM: Presidency bridging conference a great success, HTA compromise agreed and data on the agenda - EU Reporter - July 6th, 2021
- Legally blind Great Falls filmmakers share their vision in national challenge - Yahoo News - April 4th, 2021
- Pfizer Announces Vaccine Is 100% Protective Against Coronavirus In Kids As Young As 12 - Yahoo News - April 4th, 2021
- How the law will change in 2021 - Lexology - February 11th, 2021
- Writing is the best medicine - The London Economic - February 11th, 2021
- Misleading glyphosate-cancer study Part 2: 'Symptom of a widespread problem'Concerns about ideological activism in science research and communications... - February 11th, 2021
- The Error of Fighting a Public Health War With Medical Weapons - WIRED - January 2nd, 2021
- Moderna, Pfizer vaccine trials were the highest of quality: vaccine expert - Yahoo Money - January 2nd, 2021
- Celebrate the new year with this New Year's Eve fireworks show in SF - Yahoo News - January 2nd, 2021
- The movie industry will strengthen again around April or May: Screenvision CEO - Yahoo Money - January 2nd, 2021
- Congress overrides Donald Trump's veto of a defense policy bill in the first such rebuke of his presidency - Yahoo News - January 2nd, 2021
- How the pandemic enabled a robot revolution - Politico - December 4th, 2020
- The mink link: How COVID-19 mutations in animals affect human health and vaccine effectiveness - The Conversation CA - November 24th, 2020
- How vaccines get made and approved in the US - The Albany Herald - November 24th, 2020
- Legalization votes bring worries of increased youth marijuana use, but evidence remains murky - AberdeenNews.com - November 24th, 2020
- Your daily 6: Third vaccine looks effective, no single 'word of the year' and Trump team called 'a national embarrassment' - Ravalli Republic - November 24th, 2020
- Cybersecurity depends on the user - Modern Diplomacy - November 20th, 2020
- It's Been Exactly One Year Since the First Case of COVID Was Found in China - Newsweek - November 20th, 2020
- Risks and benefits of an AI revolution in medicine - Harvard Gazette - November 12th, 2020
- HHS eased oversight of Covid-19 tests though it knew of problems - STAT - November 3rd, 2020
- Who won this years Nobel science prizes? - The Economist - October 8th, 2020
- Patent and Patient Rights in COVID-19: Is the Right to Exclusivity a Hamlet Question? - The Leaflet - October 8th, 2020
- FDA Oversight of Laboratory-Developed Tests Continues To Evolve - JD Supra - October 8th, 2020
- One Sperm Donor. 36 Children. A Mess of Lawsuits. - The Atlantic - September 15th, 2020
- Nebraska Medical Bill initiative blocked from entering the November ballots - Cannabis Health Insider - September 15th, 2020
- Poaching pressure mounts on jaguars, the Americas' iconic big cat - Mongabay.com - September 15th, 2020
- 'There is a sense of being robbed': Olympian Caster Semenya loses appeal on testosterone rule - The World - September 15th, 2020
- Global Microbiome Sequencing Market Growth Drivers, Demands, Business Opportunities and Demand Forecast to 2026|Clinical-Microbiomics A/S; Diversigen;... - September 5th, 2020
- Legal and Regulatory Issues in Genetic Information ... - August 31st, 2020
- The legal aspects of genetic testing - Medical Defence Union - August 31st, 2020
- Their view: Now is not the time to legalize marijuana - Wilkes Barre Times-Leader - August 31st, 2020
- Weighing up the potential benefits and harms of comprehensive full body health checks - Croakey - August 24th, 2020
- Soon, India will have its dedicated vaccine portal: ICMR - ETHealthworld.com - August 24th, 2020
- Two Families, Two Fates: When the Misdiagnosis is Child Abuse - The Marshall Project - August 22nd, 2020
- Ron Evans steals a trick from I/O, and points the way to a transformational diabetes therapy - Endpoints News - August 22nd, 2020
- Contact tracing apps may be ineffective for reducing Covid-19 spread: Study - ETHealthworld.com - August 22nd, 2020
- Global Microbiome Sequencing Market Size 2020 Review, Growth Strategy, Developing Technologies And Forecast By 2026|Charles River; CoreBiome, Inc.;... - August 19th, 2020
- Bill Jones: Working to create a culture of education - Wilkes Barre Times-Leader - August 19th, 2020
- Whats next for abortion legislation in the U.S.? - PBS NewsHour - July 10th, 2020
- No ethics when it comes to US enemies, even in the middle of a deadly pandemic - IOL - July 10th, 2020
- IML conducts the 5th National Convention on Medicine and Law - ETHealthworld.com - July 10th, 2020
- Wayne Medicine and Wayne Law professors team up to explore legal and ethical issues of wastewater monitoring for COVID-19 - The South End - June 28th, 2020
- Challenge trials aren't the answer to a speedy Covid-19 vaccine - STAT - June 28th, 2020
- Trump Suspends H-1B and Other Visas That Allow Foreigners to Work in the U.S. - The New York Times - June 24th, 2020
- Could the Montreal Neuro herald a paradigm shift in scientific research? - University Affairs - June 24th, 2020
- Next-Generation Sequencing Market: Understanding The Key Product Segments And Their Future During 2020 -2025 - 3rd Watch News - June 24th, 2020
- Meet 'Gastruloid': The First Human Embryo-like Model From Stem Cells That Could Soon Save Many Babie - Science Times - June 12th, 2020
- Could these senolytic drugs halt the spread of COVID-19? - Health Europa - June 12th, 2020
- The coronavirus vaccine frontrunners have emerged. Here's where they stand - BioPharma Dive - June 12th, 2020
- Regulating marine genetic resources in areas beyond national jurisdiction - The Daily Star - June 12th, 2020
- Vaccines have saved millions of lives, but history shows missteps can prove deadly - The Boston Globe - June 12th, 2020
- Quitting smoking might reduce severe coronavirus infection risk: Study - ETHealthworld.com - May 23rd, 2020
- Where Taiwan Can Make the Most of AI - Taiwan - Taiwan Business TOPICS - May 23rd, 2020
- WHO and IOC team up to improve health through sport - ETHealthworld.com - May 18th, 2020
- The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) -... - May 15th, 2020
- Medical School: Who gets in and why - Stuff.co.nz - May 15th, 2020
- Wilson Ighodalo: Addressing Substance Abuse as a Public Health Problem - THISDAY Newspapers - May 15th, 2020
- The Falsehoods of the 'Plandemic' Video - FactCheck.org - May 14th, 2020
- Robert Youngjohns, Chairman of the Board, ABBYY - Interview Series - Unite.AI - May 14th, 2020